4Barlogie B. High-does therapy and innovative approaches to treatment of multiple myeloma[J]. Semin Hematol, 2001, 38(2 suppl 3): S21-S27.
5Johnston RE, Abdalla SH. Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukemia[J]. Leuk Lymphoma, 2002, 43(2): 351-354.
6Hideshima T, Chauhan D, Shima Y, et al. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy[J]. Blood, 2000, 96(11): 2943-2950.
7Singhal s,Mehta J,Desikan R,et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med, 1999,341:1565- 1571
8Weber DM,Rankin K,Gavino M,et al.Thalidomide with dexamethasone for resistant multiple myeloma.Blood,2000,96:719.
9Dimopoulos MA,Zervas K,Galani E.Thalidomide and dexamethasone combination for multiple myeloma refractory to dexamethasone-based regimens.Blood,2000,96:497a.
10Ahmad l,Islam T,Chanan-Khan A,et al.Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.Bone Marrow Transplant,2002,29(7):577～580.
